ARK Genomic Revolution ETF vs Rivian Automotive, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $44.53, while Rivian Automotive, Inc. trades at $15.97 (market cap $23.69B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Rivian Automotive, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | RIVN | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $44.55 | $22.45 |
52-Week Low | $24.02 | $11.97 |
Market Cap | — | $23.69B |
Enterprise Value | — | $23.73B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rivian (RIVN) trades at $16.005, down 2.35% on the day, with a bullish technical signal from moving averages but mixed oscillators. The company continues to report significant losses, with a net income margin of -54.95% for 2025, though revenue has grown to $5.39 billion. Recent news highlights the R2 vehicle launch and a partnership with Uber, providing potential growth catalysts amid ongoing cash burn concerns.
The outlook remains speculative; RIVN offers high growth potential through new vehicle ramps and software margins, but substantial execution risks and negative cash flow pose threats to near-term stability. Analyst consensus is cautiously optimistic with a $18.70 price target, yet the stock's path depends heavily on achieving profitability milestones.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →